REPH
Price:
$2.09
Market Cap:
$116.13M
Recro Pharma, Inc. operates as a contract development and manufacturing organization (CDMO), offering comprehensive services for the development, production, and packaging of diverse therapeutic dosage forms. The company primarily specializes in small molecule therapeutic development, serving both domestic U.S. and international clients. Its extensive capabilities encompass a wide array of formats, including oral solid doses, sterile injectable solutions, oral liquid preparations, tablets, topical formulations, liquid/powder-filled capsules, ophthalmic droppers, liposomal products, and nano/microparticles. Furthermore, Recro Pharma provides specialized services such as aseptic fill/finish, l...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2014-03-07
Stock Exchange
NASDAQ
Ticker
REPH
According to Recro Pharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -8.04. This represents a change of 18.57% compared to the average of -6.78 of the last 4 quarters.
The mean historical PE Ratio of Recro Pharma, Inc. over the last ten years is -0.78. The current -8.04 PE Ratio has changed 103.51% with respect to the historical average. Over the past ten years (40 quarters), REPH's PE Ratio was at its highest in in the June 2021 quarter at 19.25. The PE Ratio was at its lowest in in the June 2019 quarter at -17.60.
Average
-0.78
Median
-2.53
Minimum
-10.72
Maximum
22.42
Discovering the peaks and valleys of Recro Pharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 556.28%
Maximum Annual PE Ratio = 22.42
Minimum Annual Increase = -2359.11%
Minimum Annual PE Ratio = -10.72
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -2.50 | -42.87% |
| 2022 | -4.38 | 53.77% |
| 2021 | -2.85 | 97.00% |
| 2020 | -1.45 | -86.50% |
| 2019 | -10.72 | 556.28% |
| 2018 | -1.63 | -47.03% |
| 2017 | -3.08 | 20.28% |
| 2016 | -2.56 | -111.44% |
| 2015 | 22.42 | -2359.11% |
| 2014 | -0.99 | -96.40% |
The current PE Ratio of Recro Pharma, Inc. (REPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-3.25
5-year avg
-4.38
10-year avg
-0.78
Recro Pharma, Inc.’s PE Ratio is greater than Theratechnologies Inc. (-36.84), less than Theseus Pharmaceuticals, Inc. (-3.33), less than BioSig Technologies, Inc. (-0.08), less than LENZ Therapeutics, Inc. (-1.14), less than Shineco, Inc. (-0.00), less than LakeShore Biopharma Co., Ltd (-0.48), less than Vaccitech plc (-0.60), less than Zevra Therapeutics, Inc. (12.36), less than F-star Therapeutics, Inc. (-3.79), less than Procaps Group S.A. (0.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -36.84 | $155.87M | |
| -3.33 | $181.50M | |
| -0.08 | $191.13M | |
| -1.14 | $146.74M | |
| -0.00 | $94.00 | |
| -0.48 | $25.84M | |
| -0.60 | $192.73M | |
| 12.36 | $701.70M | |
| -3.79 | $156.51M | |
| 0.00 | $102.08M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Recro Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Recro Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Recro Pharma, Inc.'s PE Ratio?
How is the PE Ratio calculated for Recro Pharma, Inc. (REPH)?
What is the highest PE Ratio for Recro Pharma, Inc. (REPH)?
What is the 3-year average PE Ratio for Recro Pharma, Inc. (REPH)?
What is the 5-year average PE Ratio for Recro Pharma, Inc. (REPH)?
How does the current PE Ratio for Recro Pharma, Inc. (REPH) compare to its historical average?